ES2084174T3 - Productos y procesos para el tratamiento del conducto alimentario. - Google Patents
Productos y procesos para el tratamiento del conducto alimentario.Info
- Publication number
- ES2084174T3 ES2084174T3 ES91913651T ES91913651T ES2084174T3 ES 2084174 T3 ES2084174 T3 ES 2084174T3 ES 91913651 T ES91913651 T ES 91913651T ES 91913651 T ES91913651 T ES 91913651T ES 2084174 T3 ES2084174 T3 ES 2084174T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- treatment
- bismuth
- products
- processes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Medicinal Preparation (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
SE DESCRIBEN COMPLEJOS DE BISMUTO, POR EJEMPLO SALES DE BISMUTO, Y POLIACRILATO, POR EJEMPLO CARBOMERO, QUE SE PUEDEN INCORPORAR A COMPOSICIONES FARMACEUTICAS PARA ADMINISTRACION ORAL, ORAL DE LIBERACION RETARDADA Y RECTAL. LOS COMPLEJOS SE PUEDEN COMBINAR CON UN ANTIBIOTICO, COMO LA TETRACICLINA, Y UN AGENTE ANTIPROTOZOARIO, POR EJEMPLO EL METRONIDAZOL, PARA USO EN EL TRATAMIENTO DE LA INFECCION CAUSADA POR EL HELICOBACTER PYLORI. TAMBIEN SE DESCRIBE EL TRATAMIENTO DE LA ENFERMEDAD DEL INTESTINO INFLAMATORIO UTILIZANDO COMPLEJOS DE BISMUTO/POLIACRILATO U OTRAS PREPARACIONES DE BISMUTO.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909015988A GB9015988D0 (en) | 1990-07-20 | 1990-07-20 | Pharmaceutical composition |
GB919101675A GB9101675D0 (en) | 1991-01-25 | 1991-01-25 | Pharmaceutical composition |
GB9103795A GB2253346A (en) | 1991-02-22 | 1991-02-22 | Delayed release oral dosage forms for treatment of intestinal disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2084174T3 true ES2084174T3 (es) | 1996-05-01 |
Family
ID=27265192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91913651T Expired - Lifetime ES2084174T3 (es) | 1990-07-20 | 1991-07-19 | Productos y procesos para el tratamiento del conducto alimentario. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5843482A (es) |
EP (1) | EP0540613B1 (es) |
JP (1) | JP2688541B2 (es) |
KR (1) | KR100193933B1 (es) |
AT (1) | ATE135227T1 (es) |
AU (1) | AU648574B2 (es) |
BG (1) | BG62037B1 (es) |
CA (1) | CA2087596A1 (es) |
CZ (1) | CZ386292A3 (es) |
DE (1) | DE69117955T2 (es) |
DK (1) | DK0540613T3 (es) |
ES (1) | ES2084174T3 (es) |
FI (1) | FI97952C (es) |
GB (1) | GB2262286B (es) |
GR (1) | GR3019790T3 (es) |
HU (1) | HUT64080A (es) |
IE (1) | IE65964B1 (es) |
NO (2) | NO302684B1 (es) |
WO (1) | WO1992001457A1 (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE192932T1 (de) * | 1993-09-09 | 2000-06-15 | Takeda Chemical Industries Ltd | Formulierung enthaltend einen antibakteriellen und einen antiulcus wirkstoff |
US5549911A (en) * | 1994-01-14 | 1996-08-27 | Laboratoires Des Produits Ethiques Ethypharm | Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract |
SE502628C2 (sv) * | 1994-02-04 | 1995-11-27 | Nobel Chemicals Ab | Förfarande för framställning av ett vattenlösligt komplex av vismut och en polyakrylsyra |
US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
US6902738B2 (en) | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
GB9414699D0 (en) * | 1994-07-21 | 1994-09-07 | Slagel David | Aqueous foamable composition |
GB9501560D0 (en) | 1995-01-26 | 1995-03-15 | Nycomed Imaging As | Contrast agents |
AU4493796A (en) * | 1995-01-26 | 1996-08-14 | Nycomed Imaging As | Bismuth compounds |
US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
ES2192219T3 (es) * | 1995-12-07 | 2003-10-01 | Procter & Gamble | Composiciones para la prevencion y tratamiento de trastornos urogenitales, que contienen bismuto. |
US5702729A (en) * | 1995-12-07 | 1997-12-30 | The Procter & Gamble Company | Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria |
US5827543A (en) * | 1995-12-07 | 1998-10-27 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of urogenital disorders |
US6051604A (en) * | 1995-12-07 | 2000-04-18 | The Proctor & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
EP0865285B1 (en) * | 1995-12-07 | 2002-01-16 | The Procter & Gamble Company | Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders |
US5744168A (en) * | 1995-12-07 | 1998-04-28 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
US5889028A (en) * | 1996-02-09 | 1999-03-30 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
US5846983A (en) * | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
GB9607955D0 (en) * | 1996-04-17 | 1996-06-19 | Tillotts Pharma Ag | Hydrophobic carbomer salt compositions |
GB9620709D0 (en) * | 1996-10-04 | 1996-11-20 | Danbiosyst Uk | Colonic delivery of weak acid drugs |
GB9623962D0 (en) * | 1996-11-15 | 1997-01-08 | Tillotts Pharma Ag | Pharmaceutical composition |
US6114382A (en) * | 1998-11-11 | 2000-09-05 | Moretti; Itagiba G. | Methods for treating inflammatory bowel disease |
IN191482B (es) * | 1999-03-19 | 2003-12-06 | Ranbaxy Lab Ltd | |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
AU2001282064B2 (en) * | 2000-08-03 | 2007-02-01 | Antares Pharma Ipl Ag | Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
US7198801B2 (en) | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
JP4947851B2 (ja) * | 2001-06-07 | 2012-06-06 | 信紘 佐藤 | 潰瘍性大腸炎治療薬 |
AU2004283431B2 (en) | 2003-10-10 | 2009-09-10 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
WO2007124250A2 (en) | 2006-04-21 | 2007-11-01 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
US8067399B2 (en) | 2005-05-27 | 2011-11-29 | Antares Pharma Ipl Ag | Method and apparatus for transdermal or transmucosal application of testosterone |
WO2008052294A1 (en) * | 2006-10-30 | 2008-05-08 | Universidade Federal De Minas Gerais | Preparation of compounds of cyclodextrins and derivatives thereof with bismuth compounds |
WO2008073517A1 (en) * | 2006-12-07 | 2008-06-19 | Ehrenpreis Eli D | Treatment for intestinal gas, bloating, microscopic colitis and traveler's diarrhea using colloidal bismuth subcitrate |
US7645801B2 (en) * | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
WO2008097850A1 (en) * | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tretracycline compositions for topical administration |
US20080188446A1 (en) * | 2007-02-02 | 2008-08-07 | Warner Chilcott Company Inc. | Tetracycline compositions for topical administration |
RU2605615C2 (ru) * | 2014-07-15 | 2016-12-27 | Общество с ограниченной ответственностью "Гелизовит" | Ректальный поликомплексный гель для лечения язвенного колита, болезни крона, свищей и осложнений, вызванных этими заболеваниями |
WO2024022447A1 (zh) * | 2022-07-29 | 2024-02-01 | 上海交通大学 | 铋-高分子复合物在消化道可视化中的用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2218934C2 (de) * | 1972-04-19 | 1974-04-18 | Norddeutsche Affinerie | Verfahren zur Vermeidung von Übersättigung der Elektrolytlösungen an einer oder mehreren der Verunreinigungen Arsen, Antimon, Wismut bei der elektrolytischen Raffination von Nichteisenmetallen, insb. Kupfer |
ZA74385B (en) * | 1974-01-18 | 1975-08-27 | Gist Brocades Nv | Pharmaceutical compositions |
HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
EP0217440A1 (en) * | 1985-09-27 | 1987-04-08 | The Procter & Gamble Company | Stable aqueous pharmaceutical suspensions |
US4837378A (en) * | 1986-01-15 | 1989-06-06 | Curatek Pharmaceuticals, Inc. | Topical metronidazole formulations and therapeutic uses thereof |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
ATE81011T1 (de) * | 1987-03-09 | 1992-10-15 | Procter & Gamble | Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen. |
US5196205A (en) * | 1987-10-12 | 1993-03-23 | Borody Thomas J | Method for treatment of gastro intestinal disorders |
US4940695A (en) * | 1987-12-10 | 1990-07-10 | The Procter & Gamble Company | Bismuth-containing pharmaceutical compositions |
GB8817015D0 (en) * | 1988-07-16 | 1988-08-17 | Reckitt & Colmann Prod Ltd | Method of treatment |
CH679582A5 (es) * | 1988-07-18 | 1992-03-13 | Glaxo Group Ltd | |
AU641903B2 (en) * | 1988-10-26 | 1993-10-07 | Glaxo Group Limited | Carboxylic acid derivatives |
US5128140A (en) * | 1991-01-14 | 1992-07-07 | The Procter & Gamble Company | Swallowable pharmaceutical compositions |
-
1991
- 1991-07-19 DK DK91913651.5T patent/DK0540613T3/da active
- 1991-07-19 JP JP3512557A patent/JP2688541B2/ja not_active Expired - Lifetime
- 1991-07-19 AT AT91913651T patent/ATE135227T1/de not_active IP Right Cessation
- 1991-07-19 DE DE69117955T patent/DE69117955T2/de not_active Expired - Fee Related
- 1991-07-19 WO PCT/GB1991/001209 patent/WO1992001457A1/en not_active Application Discontinuation
- 1991-07-19 AU AU82348/91A patent/AU648574B2/en not_active Ceased
- 1991-07-19 ES ES91913651T patent/ES2084174T3/es not_active Expired - Lifetime
- 1991-07-19 KR KR1019930700162A patent/KR100193933B1/ko not_active IP Right Cessation
- 1991-07-19 US US07/966,163 patent/US5843482A/en not_active Expired - Fee Related
- 1991-07-19 EP EP91913651A patent/EP0540613B1/en not_active Expired - Lifetime
- 1991-07-19 CA CA002087596A patent/CA2087596A1/en not_active Abandoned
- 1991-07-19 HU HU93133A patent/HUT64080A/hu unknown
- 1991-07-19 IE IE254691A patent/IE65964B1/en not_active IP Right Cessation
- 1991-09-27 CZ CS923862A patent/CZ386292A3/cs unknown
-
1992
- 1992-12-28 FI FI925893A patent/FI97952C/fi active
-
1993
- 1993-01-14 GB GB9300652A patent/GB2262286B/en not_active Expired - Fee Related
- 1993-01-19 NO NO930176A patent/NO302684B1/no not_active IP Right Cessation
- 1993-02-17 BG BG97458A patent/BG62037B1/bg unknown
-
1996
- 1996-04-29 GR GR960401170T patent/GR3019790T3/el unknown
-
1997
- 1997-12-08 NO NO975779A patent/NO306046B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU648574B2 (en) | 1994-04-28 |
FI925893A0 (fi) | 1992-12-28 |
US5843482A (en) | 1998-12-01 |
EP0540613A1 (en) | 1993-05-12 |
NO306046B1 (no) | 1999-09-13 |
GB2262286A (en) | 1993-06-16 |
KR100193933B1 (ko) | 1999-06-15 |
AU8234891A (en) | 1992-02-18 |
DE69117955T2 (de) | 1996-09-19 |
FI925893A (fi) | 1992-12-28 |
GB9300652D0 (en) | 1993-03-10 |
BG62037B1 (bg) | 1999-01-29 |
BG97458A (bg) | 1994-03-31 |
DK0540613T3 (da) | 1996-04-01 |
NO930176D0 (no) | 1993-01-19 |
GB2262286B (en) | 1994-10-12 |
IE65964B1 (en) | 1996-01-24 |
NO975779L (no) | 1997-12-08 |
EP0540613B1 (en) | 1996-03-13 |
HUT64080A (en) | 1993-11-29 |
JP2688541B2 (ja) | 1997-12-10 |
CZ386292A3 (en) | 1993-12-15 |
DE69117955D1 (de) | 1996-04-18 |
FI97952B (fi) | 1996-12-13 |
GR3019790T3 (en) | 1996-07-31 |
FI97952C (fi) | 1997-03-25 |
NO302684B1 (no) | 1998-04-14 |
ATE135227T1 (de) | 1996-03-15 |
JPH06502431A (ja) | 1994-03-17 |
HU9300133D0 (en) | 1993-04-28 |
IE912546A1 (en) | 1992-01-29 |
CA2087596A1 (en) | 1992-01-21 |
NO975779D0 (no) | 1997-12-08 |
WO1992001457A1 (en) | 1992-02-06 |
NO930176L (no) | 1993-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2084174T3 (es) | Productos y procesos para el tratamiento del conducto alimentario. | |
IL111077A (en) | Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them | |
PH24492A (en) | New diazoles | |
KR930005619A (ko) | 위장 질환 치료용 약제 | |
IS2742B (is) | Samsetning@sem@nær@yfir@basískan@svingómýelínasa@af@bakteríuuppruna@til@nota@sem@næringarfræðileg@efnablanda@@fæðubótarefni@eða@lyfjaafurð | |
ES476109A1 (es) | Procedimiento para la preparacion de derivados de cefalospo-rina | |
ITRM920900A1 (it) | Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale. | |
SE9201930D0 (sv) | Gastric antibacterial treatment | |
ES2116612T3 (es) | Nuevas bis-naftalimidas para el tratamiento del cancer. | |
DK0561846T3 (da) | 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning | |
JPS51128438A (en) | An antibacterial drug against fish diseases | |
ATE190845T1 (de) | Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen | |
JPS5238376A (en) | Fodder for pig raising | |
GB976096A (en) | Pharmaceutical compositions | |
JPS51137414A (en) | Endoscope | |
GB878432A (en) | Therapeutic compositions containing sulphonamides | |
GB1072263A (en) | Therapeutic compositions for use in the treatment of the common cold | |
JPS5210425A (en) | An antibiotic pharmaceutical with low reaction | |
JPS51151325A (en) | Agricultural germicide | |
JPS52117438A (en) | Antibacterial agent for diseases of fishes | |
MX9710126A (es) | Compuestos sustituidos con sulfonamida, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que los contienen. | |
JPS53144502A (en) | New antibiotics tridecaptin b and its preparation | |
GB1072262A (en) | Therapeutic compositions comprising synergised antihistamines and antipyretics | |
JPS5695117A (en) | Drug composition having analgesic, antipyretic and anti-infalmmatory action | |
ES2163986B1 (es) | Acidos-alfa-arilpropionicos y arilaceticos como inhibidores de la ciclooxigenasa-ii. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 540613 Country of ref document: ES |